Editas Medicine (EDIT) Gains from Investment Securities (2015 - 2025)
Editas Medicine (EDIT) reported Gains from Investment Securities of $1.2 million for Q3 2025, up 140.76% year-over-year from $484712.2 in Q3 2024, and up 199.91% on a QoQ basis from -$1.2 million in Q2 2025.
Editas Medicine (EDIT) has 11 years of Gains from Investment Securities data on file, last reported at $1.2 million in Q3 2025.
- Quarterly Gains from Investment Securities rose 140.76% year-over-year to $1.2 million in Q3 2025, while the trailing twelve-month figure through Sep 2025 was -$1.1 million (down 2.84% YoY) and the FY2024 annual result came in at -$3.4 million, down 222.31% from the prior year.
- Gains from Investment Securities improved to $1.2 million in Q3 2025 per EDIT's latest filing, from -$1.2 million in the prior quarter.
- Across five years, Gains from Investment Securities topped out at $6.2 million in Q2 2023 and bottomed at -$7.6 million in Q4 2021.
- The 5-year median for Gains from Investment Securities is $341978.0 (2021), against an average of $125499.2.
- The widest annual swing landed in 2021, when Gains from Investment Securities slumped 1026.67%; it then soared 1425.28% in 2022.
- Tracing EDIT's Gains from Investment Securities over 5 years: stood at -$7.6 million in 2021, then jumped by 38.42% to -$4.7 million in 2022, then soared by 147.79% to $2.2 million in 2023, then tumbled by 102.67% to -$60000.0 in 2024, then surged by 2045.0% to $1.2 million in 2025.
- Per Business Quant, the three latest EDIT Gains from Investment Securities figures stand at $1.2 million (Q3 2025), -$1.2 million (Q2 2025), and -$1.0 million (Q1 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | Editas Medicine | 338.62 Mn | 338.62 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 1.17 Mn |
| Sep 30, 2025 | 1.17 Mn |
| Jun 30, 2025 | -1.17 Mn |
| Jun 30, 2025 | -1.17 Mn |
| Mar 31, 2025 | -1.03 Mn |
| Mar 31, 2025 | -1.03 Mn |
| Dec 31, 2024 | -60,000.00 |
| Dec 31, 2024 | -60,000.00 |
| Sep 30, 2024 | -2.86 Mn |
| Sep 30, 2024 | -2.86 Mn |
| Jun 30, 2024 | -1.24 Mn |
| Jun 30, 2024 | -1.24 Mn |
| Mar 31, 2024 | 794,000.00 |
| Mar 31, 2024 | 794,000.00 |
| Dec 31, 2023 | 2.25 Mn |
| Dec 31, 2023 | 2.25 Mn |
| Sep 30, 2023 | 502,000.00 |
| Sep 30, 2023 | 502,000.00 |
| Jun 30, 2023 | 6.19 Mn |
| Jun 30, 2023 | 6.19 Mn |
| Mar 31, 2023 | 1.50 Mn |
| Mar 31, 2023 | 1.50 Mn |
| Dec 31, 2022 | -4.71 Mn |
| Dec 31, 2022 | -4.71 Mn |
| Sep 30, 2022 | 5.22 Mn |
| Sep 30, 2022 | 5.22 Mn |
| Jun 30, 2022 | 1.18 Mn |
| Jun 30, 2022 | 1.18 Mn |
| Mar 31, 2022 | -234,000.00 |
| Mar 31, 2022 | -234,000.00 |
| Dec 31, 2021 | -7.65 Mn |
| Dec 31, 2021 | -7.65 Mn |
| Sep 30, 2021 | 341,978.00 |
| Sep 30, 2021 | 341,978.00 |
| Jun 30, 2021 | 196,637.00 |
| Jun 30, 2021 | 196,637.00 |
| Mar 31, 2021 | 1.99 Mn |
| Mar 31, 2021 | 1.99 Mn |
| Dec 31, 2020 | 825,000.00 |
| Dec 31, 2020 | 825,000.00 |
| Sep 30, 2020 | 1.10 Mn |
| Sep 30, 2020 | 1.10 Mn |
| Jun 30, 2020 | 1.23 Mn |
| Jun 30, 2020 | 1.23 Mn |
| Mar 31, 2020 | 215,000.00 |
| Mar 31, 2020 | 215,000.00 |
| Dec 31, 2019 | -16.53 Mn |
| Dec 31, 2019 | -16.53 Mn |
| Sep 30, 2019 | 5.14 Mn |
| Sep 30, 2019 | 5.14 Mn |
| Jun 30, 2019 | 467,185.00 |
| Jun 30, 2019 | 467,185.00 |
| Mar 31, 2019 | 4.86 Mn |
| Mar 31, 2019 | 4.86 Mn |
| Dec 31, 2018 | 1.14 Mn |
| Dec 31, 2018 | 1.14 Mn |
| Sep 30, 2018 | 4.82 Mn |
| Sep 30, 2018 | 4.82 Mn |
| Jun 30, 2018 | 1.56 Mn |
| Jun 30, 2018 | 1.56 Mn |
| Mar 31, 2018 | 430,000.00 |
| Mar 31, 2018 | 430,000.00 |
| Sep 30, 2017 | 4.42 Mn |
| Sep 30, 2017 | 4.42 Mn |
| Jun 30, 2017 | 1.22 Mn |
| Jun 30, 2017 | 1.22 Mn |
| Mar 31, 2017 | -69,000.00 |
| Mar 31, 2017 | -69,000.00 |
| Dec 31, 2016 | -1.98 Mn |
| Dec 31, 2016 | -1.98 Mn |
| Mar 31, 2016 | -2.25 Mn |
| Mar 31, 2016 | -2.25 Mn |
| Dec 31, 2015 | -145,000.00 |
| Dec 31, 2015 | -145,000.00 |
| Sep 30, 2015 | 13,000.00 |
| Sep 30, 2015 | 13,000.00 |